Creating Accessibility to Cell and Gene Therapies
Impossible. Incurable. Inaccessible.
Our reinsurance solutions provide cost effective and comprehensive coverage for members that aligns payors and manufacturers to achieve optimal clinical and financial outcomes.
Who We Serve
We provide specialized expertise and multifaceted solutions for the reinsurance and warranty of cell and gene therapies (CGTs). Our focus is to deliver patient access and superior clinical and financial outcomes while aligning interests across the spectrum of stakeholders.
As an independent party, we are payor-agnostic. We can partner with our clients as a stand-alone entity without disrupting existing vendor relationships.
Click below to learn how we can partner with you.
Deliver Financial Stability to Your Clients
We recognize the valuable role of the insurance brokerage community as trusted advisors to inform their clients about critical business risk issues and concerns.
OutcomeRx works collaboratively with brokers to educate their clients on the rapidly evolving CGT market and provide flexible solutions that best address the exposure for their business and their employees. We work with the wide spectrum of wholesale specialty, retail brokers and agents, benefit brokers and consultants, and reinsurance experts.
Scroll down to learn more
Approved Cell and Gene Therapies Are Increasing.
So Should Your Coverage.
Cell and gene therapies (CGTs) are moving quickly through the FDA pipeline. Whether you're a broker or TPA looking for client solutions, or an insurance carrier, captive, or MGU looking to protect your business block, it's time to add protective coverage and take back stability.
Amplify Your Protection
These potentially life-saving therapies come with multi-million-dollar price tags attached, and the costs are going nowhere but up. It's time to fill the holes in your coverage with PACCT.
Highly customizable first-dollar coverage
solution for CGTs backed by A rated carriers
Member access to quality care at top facilities
Data insights that capture essential quality measures
Financial predictability and laser protection
Implement at any time
Stay ahead of new risk exposure and access coverage options that include future FDA approvals with PACCT.
Download our resources and contact us to learn more.
Reducing Uncertainty with Therapy Warranty
OutcomeRx's Cell & Gene Therapy (CGT) Warranties align healthcare stakeholders around patient access and durable clinical outcomes.
As more CGTs gain FDA approval, OutcomeRx can bridge the needs of payors and manufacturers by designing and administering therapy-specific warranties.
Features
A therapy-specific warranty structure that mitigates financial risk and uncertainty, and improve patient access to CGTs
Flexibility for a wide array of warranty coverage options that can benefit payors, providers, or patients
Fits within existing payor and provider claims management workflows to minimize administrative burdens.
Dedicated OutcomeRx team to design, develop and manage warranty programs, including claims management
Benefits
Easy to administer
Removes barriers to patient access
Differentiates your business without increasing risk
Complementary to OutcomeRx’s PACCT for payors
The Challenge
Value-based agreements represent alternative options to address payor concerns about cell and gene-based therapy efficacy and durability. While these options can provide a measure of risk protection, they can also be limited in coverage scope, reimbursement terms, and administratively complex for payors and providers.
The Resolution
OutcomeRx’s therapy-specific Therapy Warranties can mitigate payor and manufacturer challenges and help improve provider and patient access to CGTs. OutcomeRx serves as an independent third party, providing the insurance infrastructure that bridges gaps between all key stakeholders.
About Us
OutcomeRx is accelerating patient access to curative therapies. We strive to provide our clients with premier underwriting, actuarial, and clinical resources so that patients have seamless connections to top care facilities for novel cell and gene-based therapies.
Our Mission
Accelerating patient access to curative therapies through payor risk predictability and outcome-based guarantees.
Our Vision
To provide bespoke reinsurance coverage for broad patient access to personalized treatment and care management at credentialed Centers of Excellence and to align clinical and financial outcomes for both payors and manufacturers
Our Values
We believe in:
- Patient-Centric Care – Each decision we make is centered around improving patient outcomes and reducing their financial burden.
- Service Excellence – We provide premier service to our clients in everything we do to ensure their goals and expectations are fully met.
- Continual Innovation – Our dedication to maintaining thought leadership and anticipating market changes drives our ever-evolving solutions and delivery to clients.
- Trust – Our actions and decisions are motivated by building and nurturing trust in each relationship.
Our Team
Joe Morse
Chief Executive Officer
Joe serves as CEO of OutcomeRx. With 28 years in the healthcare industry, Joe has worked with every key stakeholder to align and deliver patient-centric solutions and services.
In 2006, he co-founded Therigy, LLC and served as President & CEO, overseeing its consulting and technology solutions for pharmacies, payors, and manufacturers. Prior to Therigy, he held the position of Vice President of Business & Corporate Development at the Aetna Specialty Pharmacy. Previously he served as Vice President of Business & Corporate Development with Priority Healthcare, where he applied his managed care expertise. Joe began his career at Accenture as a Manager in the Health Services Practice working with national and regional health plans on strategy, technology, and managed care initiatives.
Joe received a B.A. in Economics from the University of Florida. He has served and supported the Leukemia and Lymphoma Society for over 15 years. Joe collaborates with industry colleagues by serving on the Board of Directors for the National Association of Specialty Pharmacy as well as the Cell & Gene Task Force for the Self-Insurance Institute of America (SIIA).
Brooks Wildasin
Chief Underwriting Officer
Brooks is a co-founder of OutcomeRx and currently serves as the Chief Underwriting Officer. Leveraging over 15 years of healthcare solution innovation, specialty pharmaceutical market plus Cell and Gene Therapies subject matter expertise, Brooks leads all reinsurance and insurance activities and new product development.
Prior to OutcomeRx, Brooks worked across healthcare sectors with pharmaceutical manufacturers, government and commercial payers, and non-profit entities to develop technology, operations, and financial solutions.
Throughout his career, his passion for innovative product development has inspired multiple market trend solutions for Cell and Gene Therapies plus industry-wide regulatory changes including the ACA and the expansion of value-based care. Today, Brooks is an active participant in Self Insurance Institute of America (SIIA), Tufts NEWDIGS, and is a frequent speaker in leading national healthcare organizations.
Kirby Eng, R. Ph.
Chief Clinical Officer
Kirby has served in a wide array of senior and executive healthcare leadership positions within managed care, specialty pharmacy, healthcare consulting, healthcare technology, provider development, group purchasing, specialty distribution, and pharmaceutical manufacturers.
Before OutcomeRx, Kirby’s key roles and responsibilities included developing clinical oncology and specialty drug management solutions, business development, strategic planning, sales, and marketing representing organizations that included D2 Solutions, Onco360, CVS Health, CuraScript/ExpressScript, US Oncology, Oncology Therapeutics Network, Sicor, Fujisawa, and Eli Lilly & Company.
As Chief Clinical Officer for OutcomeRx, Kirby is responsible for creating and implementing practical cell and gene therapy clinical solutions that are patient-centered and align key stakeholders with costeffective options that complement OutcomeRx’s reinsurance and therapy warranty solutions.
Kirby is a licensed pharmacist with a B.S. in Pharmacy from the Arnold & Marie Schwartz College of Pharmacy and is an active member of the National Association of Specialty Pharmacy, the Academy of Managed Care Pharmacy, and the American Society of Gene & Cell Therapy.
Greg Morris
Advisor
Greg serves as Strategic Advisor for OutcomeRx. Having dedicated his entire career to serving as an innovator, strategist, and successful manager in the healthcare industry, Greg also currently holds a position as Chief Strategy Officer at CareMetx, leveraging his expertise to drive forward-thinking strategies and innovations in the patient services sector.
Previously, he held the position of Chief Commercial Officer at VirMedica, where he played a pivotal role in overseeing product strategy and commercialization efforts for the company’s e-Access technology platform. In 2006, he founded TransEngen, serving as President and CEO until 2013. There, he led the transformation of the company to become the nation’s leading authority in the emerging field of automated benefits investigations for specialty therapies. Prior to TransEngen, Greg served as Chief Operating Officer at Aon’s National Healthcare Practice, building the core of the business and playing a key role is redesigning the company’s approach to risk.
Greg received a bachelor’s degree in economics from Harvard University. He is recognized as a frequent speaker on technology and innovation in patient access services.
Bill Megna
Insurance Regulatory Counsel
Mr. Megna has been in private practice for close to 4 decades. Prior to entering private practice, Mr. Megna held various in-house insurance positions including: Vice President and Counsel for Home Life Insurance, Associate Counsel and Florida Regional Council for USLIFE Corporation and Vice President and General Counsel for USLIFE Realty Corporation of Florida.
Mr. Megna has represented many clients in the formation and licensing of insurers and producers, in obtaining approval of rates and forms, as well as enforcement matters. Mr. Megna has served as counsel to the Washington, DC Life and Health Insurance Guaranty Association for over a decade. He is the co-director of the Genova Burns, LLC insurance practice group and frequently co-counsels for mutual clients with other insurance law firm regulator practice groups.
Regarded as an authority on insurance law, Mr. Megna frequently speaks on insurance matters before business and bar associations. Mr. Megna is the past Chairman of the New Jersey State Bar Association’s Insurance Section and a current trustee of the Captive Insurance Group of New Jersey. He has been listed in New Jersey Super Lawyers for insurance law and New York Area’s Best Lawyers for government relations law.
Greg Arms
Advisor
Over the course of his career, Greg has held senior executive roles with some of the industry’s foremost carriers and brokers, including Chubb, Marsh, Willis Group, UnitedHealth Group, and AIG.
Currently, Greg serves as the Senior Advisor to OutcomeRx, to elevate performance and brand prominence by fostering innovation, forging strategic partnerships, and developing talent.
Greg is an active member of the Self Insurance Institute of America (SIIA), where he serves as program Chair for the International Conference taking place in Dublin, Ireland in July 2024. Greg also is an active participant at the World Captives Forum, the South Carolina Captive Insurance Association, and the World Affairs Council of Charleston.
Daryl Davis
Chief Financial Officer
Daryl Davis is Chief Financial Officer of OutcomeRx. Prior to joining OutcomeRx, Daryl held various CFO & Controller roles in the insurance, construction and software sectors. Daryl has spent most of his career in the insurance industry, from workers’ compensation, health and Medicare, including audits, NAIC Annual Statements, state assessments and income taxes. Daryl’s experience spans both public and privately owned companies and has also accumulated extensive work in mergers and acquisitions. Daryl previously spent several years in the public accounting field and is a CPA.
Larry Bailey
Vice President of Business Development
Larry has 25 years of experience in the Life & Health insurance industry, holding senior Financial, Product, and Underwriting roles with multinational insurers, working both domestically and overseas. His international roles were concentrated in Latin America and included Regional SVP of Finance, Mexico Chief Technical Officer, and Brazil Executive Director/Chief Actuary. His domestic roles included Head of Insurance Product and Operations and Chief Product and Underwriting Officer.
Recently he has concentrated on the InsurTech side, working with Fintech/Insurtech start-ups, as well as co-founding a digital Life and A&H broker.
Larry uses his broad experience and technical background to develop data-driven insights supporting sound business decisions. He has a BS in Management, an MS in Actuarial Science, and is conversational in Portuguese and Spanish.